Responses
Oral Presentations
Cellular drivers of inflammation in rheumatic disease
OP0174 New protein array technology identifies rituximab treated non responder rheumatoid arthritis patients are generating a new autoantibody repertoire
Compose a Response to This Article
Other responses
No responses have been published for this article.